SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019659
Filing Date
2018-08-07
Accepted
2018-08-07 08:01:55
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20180630.htm 10-Q 1756454
2 EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED mack-ex31_142.htm EX-3.1 83962
3 EX-31.1 mack-ex311_10.htm EX-31.1 9561
4 EX-31.2 mack-ex312_8.htm EX-31.2 9510
5 EX-32.1 mack-ex321_9.htm EX-32.1 5730
6 EX-32.2 mack-ex322_6.htm EX-32.2 5666
  Complete submission text file 0001564590-18-019659.txt   6088836

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mack-20180630.xml EX-101.INS 1267065
8 XBRL TAXONOMY EXTENSION SCHEMA mack-20180630.xsd EX-101.SCH 40940
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20180630_cal.xml EX-101.CAL 58360
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20180630_def.xml EX-101.DEF 155102
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20180630_lab.xml EX-101.LAB 349823
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20180630_pre.xml EX-101.PRE 260350
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 18996346
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences